Shed NKG2D - L, due to proteolytic cleavage by disintegrin / metalloproteinases as ADAM10, can impair
tumor cell recognition.
Not exact matches
Zelig Eshhar and colleagues first use the T - body approach, employing chimeric receptors composed of an antibody
recognition unit linked to T
cell activation domains, to redirect T
cells to recognize and attack
tumor cells.
«We have experiments in mice that show that the combined use of PD - 1 antibody and poly - IC is synergistic for the
recognition of
tumors and an antitumor response mediated by T -
cells,» says Dr. Esteban Celis, co-leader of the Cancer Immunology, Inflammation and Tolerance program at the Georgia Cancer Center at Augusta University.
Lloyd Old, Thierry Boon, and colleagues develop the TNF release assay for mouse systems in which release of TNF by T
cells could be used to assess specific T
cell recognition, facilitating the cloning of human
tumor antigens.
Toxicity is a significant concern with CAR T -
cell therapies, since they have the capacity to elicit not only expected serious adverse events but also unexpected ones, including cytokine release syndrome (CRS), neurologic toxicity, «on target / off
tumor»
recognition, and anaphylaxis.
Central to the concept of immunoediting is the idea that T -
cell recognition of
tumor - specific antigens drives the destruction of early
tumors, and later the antigenic «sculpting» of persistent
tumor cells.
Michelle Barton, Ph.D., was nominated and elected by her scientific peers in
recognition for her contributions to understanding the function of the
tumor suppressor, p53 in stem
cells, particularly with respect to the discovery of TRIM24, an E3 - ligase and epigenetic regulator that is overexpressed in many cancers.
Matsuzaki J, Tsuji T, Luescher I, Old L, Shrikant P, Gnjatic S, Odunsi K. (2014) Non-classical antigen processing pathways are required for MHC class II - restricted direct
tumor recognition by NY - ESO -1-specific CD4 + T
cells.
Tsuji T, Matsuzaki J, Caballero OL, Jungbluth AA, Ritter G, Odunsi K, Old LJ, Gnjatic S. (2012) Heat shock protein 90 - mediated peptide - selective presentation of cytosolic
tumor antigen for direct
recognition of
tumors by CD4 + T
cells.
Specifically, some
tumor cells appeared to express PD - L1, essentially «wrapping» themselves in it to avoid immune
recognition and destruction.
A primary function of CTLs is the selective
recognition and destruction of
tumor cells.